Entrectinib: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 2 1 Phase 3 1 Not applicable 1

Condition	Trials
Brain Neoplasms	1
Cancer	1
Glioma	1
Haematological Malignancy	1
Lung cancer	1
Lymphoproliferative Disorders	1
Malignancy	1
Malignant Neoplasm	1
Melanoma	1
Neoplasms by Histologic Type	1
Neoplasms by Site	1
Non Small Cell Lung Cancer	1
ROS1 Fusion Positive	1
Solid Tumour	1

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
NCT05770544 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 27 locations
Study on the Mechanism of Acquired Resistance of Entrectinib
NCT07199959 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

2 recruiting trials across 14 conditions.

No. For the full record, search ClinicalTrials.gov.